Moderna Stabilized Spike Glycoprotein
Spike Glycoprotein Antibody |
|||
20-abx300551 | Abbexa |
|
|
Human IgG antibody Laboratories manufactures the moderna stabilized spike glycoprotein reagents distributed by Genprice. The Moderna Stabilized Spike Glycoprotein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Glycoprotein. Other Moderna products are available in stock. Specificity: Moderna Category: Stabilized Group: Spike Glycoprotein
Spike Glycoprotein Polyclonal Antibody |
||
EpiGentek |
|
|
Spike Glycoprotein Antibody (HRP) |
||
Abbexa |
|
|
Spike Glycoprotein Antibody (FITC) |
||
Abbexa |
|
|
Spike Glycoprotein Antibody (Biotin) |
||
Abbexa |
|
|
SARS-CoV-2 (B.1.1.7) Stabilized Spike Glycoprotein, His-Strep-Tag (HEK293): Biotin Conjugate |
||
The Native Antigen Company | 0.1 | EUR 718.25 |
Description: SARS-CoV-2 HexaPro stabilized Spike glycoprotein containing deletions and amino acid changes in accordance with variant B.1.1.7 (“UK variant”): 69-70del, Y144del, N501Y, A570D, P681H, T716I, S982A, D1118H relative to Wuhan-Hu-1. The polybasic furin cleavage site was changed from “RRAR” to “GSAS” to prevent cleavage of the protein during production. This protein contains 6 amino acid changes to proline and a C-terminal T4 fibritin trimerization domain to stabilize the protein in its pre-fusion conformation as described in Hsieh, Goldsmith et al. 2020. The protein was produced in HEK293 and purified from culture supernatant. Protein is conjugated to biotin. |
SARS-CoV-2 (501.V2) Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293) |
||
The Native Antigen Company | 0.1 | EUR 636.6 |
Description: SARS-CoV-2 HexaPro stabilized Spike glycoprotein containing amino acid changes in accordance with variant 501.V2 (“South African variant”): D80A, D215G, K417N, E484K, N501Y, A701V relative to Wuhan-Hu-1. This protein has the polybasic furin cleavage site “RRAR” changed to “SRAS” to prevent furin cleavage of the target protein. The protein also contains 6 amino acid changes to proline and a C-terminal T4 fibritin trimerization domain to stabilize the protein in its pre-fusion conformation as described in Hsieh, Goldsmith et al. 2020. The protein was produced in HEK293 and purified from culture supernatant. |
SARS-CoV-2 (501.V2) Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293) |
||
The Native Antigen Company | 0.5 | EUR 2421.37 |
Description: SARS-CoV-2 HexaPro stabilized Spike glycoprotein containing amino acid changes in accordance with variant 501.V2 (“South African variant”): D80A, D215G, K417N, E484K, N501Y, A701V relative to Wuhan-Hu-1. This protein has the polybasic furin cleavage site “RRAR” changed to “SRAS” to prevent furin cleavage of the target protein. The protein also contains 6 amino acid changes to proline and a C-terminal T4 fibritin trimerization domain to stabilize the protein in its pre-fusion conformation as described in Hsieh, Goldsmith et al. 2020. The protein was produced in HEK293 and purified from culture supernatant. |
Spike Glycoprotein information
SARS-CoV-2 (B.1.617.2; AY.1, AY.2, AY.3) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293) |
|||
REC31975-500 | The Native Antigen Company | 0.5 | EUR 2421.37 |
Description: SARS-CoV-2 Spike protein containing following amino acid changes: T19R, T95I, G142D, E156G, del157-158, W258L, N417K, L452R, T478K, D614G, P681R, D950N. The protein is stabilized as a pre-fusion trimer due to six amino acid changes in the S2 portion of Spike (HexaPro). The furin cleavage site has been mutated to GSAS. |
SARS-CoV-2 (B.1.351) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293): Biotin Conjugate |
|||
REC31963-Biotin-100 | The Native Antigen Company | 0.1 | EUR 718.25 |
Description: SARS-CoV-2 Spike protein, South African variant of concern. Relative to Wuhan-Hu-1 contains following amino acid changes: L18F, D80A, D215G, del242-244, K417N, E484K, N501Y, D614G, A701V. The protein contains six proline amino acid changes (commonly known as Hexapro) to stabilize it in a trimeric pre-fusion state. The furin cleavage site has been altered to 'SRAS' and deactivated. Protein is conjugated to biotin. |
SARS-CoV-2 (C.37) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293): Biotin Conjugate |
|||
REC31976-Biotin-100 | The Native Antigen Company | 0.1 | EUR 718.25 |
Description: SARS-CoV-2 Spike protein containing following amino acid changes: G75V, T76I, 246-252del, D253N, L452Q, F490S, D614G, Q675H, T859N. The protein is stabilized as a pre-fusion trimer due to six amino acid changes in the S2 portion of Spike (HexaPro). The furin cleavage site has been mutated to GSAS. Protein is conjugated to biotin. |
SARS-CoV-2 (501.V2) Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293): Biotin Conjugate |
|||
REC31926-Biotin-100 | The Native Antigen Company | 0.1 | EUR 718.25 |
Description: SARS-CoV-2 HexaPro stabilized Spike glycoprotein containing amino acid changes in accordance with variant 501.V2 (“South African variant”): D80A, D215G, K417N, E484K, N501Y, A701V relative to Wuhan-Hu-1. This protein has the polybasic furin cleavage site “RRAR” changed to “SRAS” to prevent furin cleavage of the target protein. The protein also contains 6 amino acid changes to proline and a C-terminal T4 fibritin trimerization domain to stabilize the protein in its pre-fusion conformation as described in Hsieh, Goldsmith et al. 2020. The protein was produced in HEK293 and purified from culture supernatant. Protein is conjugated to biotin. |
SARS-CoV-2 (B.1.1.28) Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293): Biotin Conjugate |
|||
REC31944-Biotin-100 | The Native Antigen Company | 0.1 | EUR 718.25 |
Description: Pre-fusion stabilized SARS-CoV-2 Spike protein of the virus variant B.1.1.28 (P1, Brazilian variant) containing amino acid changes L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I, V1176F relative to Wuhan Hu-1. The protein was produced in HEK293 cells and purified from culture supernatant. The protein was stabilized using HexaPro as described in Hsieh, Goldsmith et al. 2020. Protein is conjugated to biotin. |
SARS-CoV-2 (B.1.1.529/Omicron) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293): Biotin Conjugate |
|||
REC32008-Biotin-100 | The Native Antigen Company | 0.1 | EUR 718.25 |
Description: Recombinant SARS-CoV-2 Omicron variant Spike protein. Relative to Wuhan-Hu-1 the protein has following amino acid changes: A67V, H69del, V70del, T95I, G142D, V143del, Y144del, Y145del, N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F. The furin cleavage site has been altered to GSAS, and the protein has 6 amino acid changes in the S2 portion to stabilize trimer formation, commonly known as HexaPro. The C-terminus contains a T4 foldon domain. Protein is biotinylated. |
SARS-CoV-2 (B.1.1.529/Omicron) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293): Biotin Conjugate |
|||
REC32008-Biotin-500 | The Native Antigen Company | 0.5 | EUR 3268.47 |
Description: Recombinant SARS-CoV-2 Omicron variant Spike protein. Relative to Wuhan-Hu-1 the protein has following amino acid changes: A67V, H69del, V70del, T95I, G142D, V143del, Y144del, Y145del, N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F. The furin cleavage site has been altered to GSAS, and the protein has 6 amino acid changes in the S2 portion to stabilize trimer formation, commonly known as HexaPro. The C-terminus contains a T4 foldon domain. Protein is biotinylated. |
SARS-CoV-2 (B.1.617.2; AY.1, AY.2, AY.3) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293): Biotin Conjugate |
|||
REC31975-Biotin-100 | The Native Antigen Company | 0.1 | EUR 718.25 |
Description: SARS-CoV-2 Spike protein containing following amino acid changes: T19R, T95I, G142D, E156G, del157-158, W258L, N417K, L452R, T478K, D614G, P681R, D950N. The protein is stabilized as a pre-fusion trimer due to six amino acid changes in the S2 portion of Spike (HexaPro). The furin cleavage site has been mutated to GSAS. Protein is conjugated to biotin. |
Spike Glycoprotein Antibody |
|||
20-abx300551 | Abbexa |
|
|
Spike Glycoprotein Antibody (HRP) |
|||
20-abx300552 | Abbexa |
|
|
Spike Glycoprotein Antibody (FITC) |
|||
20-abx300553 | Abbexa |
|
|
Spike Glycoprotein Antibody (Biotin) |
|||
20-abx300554 | Abbexa |
|
|
Spike Glycoprotein Polyclonal Antibody |
|||
A57201 | EpiGentek |
|
|
Spike Glycoprotein Polyclonal Antibody |
|||
A56214 | EpiGentek |
|
|
COVID-19 Spike glycoprotein Antibody |
|||
E38PA9966 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
Bovine coronavirus Spike glycoprotein (S) |
|||
1-CSB-EP333052BJO | Cusabio |
|
|
Description: Recombinant Bovine coronavirus Spike glycoprotein(S) ,partial expressed in E.coli |
Bovine coronavirus Spike glycoprotein (S) |
|||
1-CSB-YP333052BJO | Cusabio |
|
|
Description: Recombinant Bovine coronavirus Spike glycoprotein(S),partial expressed in Yeast |